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Trends
The genetic system required for mito-
chondrial gene expression is housed
within the mitochondrial matrix, with all
the necessary RNAs being provided by
transcription of the mtDNA itself.
Our understanding of the extent and
nature of post-transcriptional modiﬁ-
cations of mtRNA, the epitranscrip-
tome, is rapidly expanding. Several
required nucleus-encoded enzymes
have recently been identiﬁed.
mtRNA maturation factors localize in
distinct foci, termed mtRNA granules,
with newly transcribed RNA. These
foci may allow spatiotemporal control
of mtRNA processing.
Recent high-resolution structures
obtained via cryo-electron microscopy
have rapidly advanced our under-
standing of the specialized adapta-
tions of the mitochondrial ribosome.
Production of respiratory complexes
requires tight coordination between
the cytoplasmic and mitochondrial
translation systems.
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Perturbation of mitochondrial DNA (mtDNA) gene expression can lead to
human pathologies. Therefore, a greater appreciation of the basic mechanisms
of mitochondrial gene expression is desirable to understand the pathophysiol-
ogy of associated disorders. Although the purpose of the mitochondrial gene
expression machinery is to provide only 13 proteins of the oxidative phosphor-
ylation (OxPhos) system, recent studies have revealed its remarkable and
unexpected complexity. We review here the latest breakthroughs in our under-
standing of the post-transcriptional processes of mitochondrial gene expres-
sion, focusing on advances in analyzing the mitochondrial epitranscriptome,
the role of mitochondrial RNA granules (MRGs), the beneﬁts of recently
obtained structures of the mitochondrial ribosome, and the coordination of
mitochondrial and cytosolic translation to orchestrate the biogenesis of
OxPhos complexes.
Mitochondria and Their Genes
Mitochondria are dynamic organelles that are present in almost all eukaryotic cells and play a
crucial role in several cellular pathways. Their most recognizable role is providing the cell with
energy in the form of ATP via OxPhos. However, many other functions have been assigned to
mitochondria, including the integration of metabolic pathways (such as the biosyntheses of
heme, iron–sulfur clusters, and nucleotides), apoptosis, and reactive oxidative species (ROS)
signaling.
The endosymbiotic theory proposes that mitochondria originated as free-living Alphapro-
teobacteria that were internalized by a pre-eukaryotic host cell, leading to the formation of
the modern eukaryotic cell. In the course of evolution, the genome of the original alphap-
roteobacterial symbiont has undergone extensive reduction. The majority of its genes have
either been lost, owing to redundancy, or transferred to the host nuclear genome. Further-
more, mitochondria have lost autonomy over their genome maintenance and expression to
the host cell. Nonetheless, in almost all cases, eukaryotic mitochondria retain a minimal
genome, of variable size and gene content, that is present in many copies within their
matrix.
Human mitochondrial DNA (mtDNA) is a circular molecule of 16.5 kb which encodes a small
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transcribed and then translated within the mitochondrial matrix by a dedicated, unique, and
highly specialized machinery. The RNA components of the mitochondrial gene expression
system, two mitochondrial ribosomal RNAs (mt-rRNAs) and 22 mt-tRNAs, are also encoded by
mtDNA, whereas all other protein components are encoded by nuclear genes and imported
into mitochondria from the cytosol. Based on published research [1,2] and our unpublished
data, we estimate that 250–300 nucleus-encoded proteins are dedicated to serve mitochon-
drial gene expression. This includes RNA polymerase and transcription factors, endonucleases
for RNA precursor processing, aminoacyl-tRNA synthetases, RNA-modifying enzymes, the
structural components and biogenesis factors for the mitochondrial ribosome, translation
factors, and other auxiliary factors.
Many mutations in mtDNA that affect the expression of mitochondria-encoded OxPhos
components are associated with human pathologies, collectively known as mitochondrial
disease. Recent growing evidence also suggests that defects in the nuclear genes involved
in mitochondrial gene expression are also one of the major cause of human mitochondrial
disease [3–5]. However, establishing the molecular details of how these defects contribute to
pathogenicity and patient phenotypes constitutes a major challenge.
Although mitochondrial gene expression requires a series of linked processes encompassing
mtDNA repair, replication, transcription (reviewed in [6,7]), and mtRNA maturation (reviewed in
[8]) through to translation (reviewed in [9]) and respiratory complex assembly (reviewed in [10]),
this article will focus in particular on the most recent advances in our understanding of the post-
transcriptional processes of mtDNA gene expression (Figure 1). In particular, we outline the
recent identiﬁcation of novel nucleus-encoded factors required for modiﬁcation or maturation of
mtRNAs, the characterization of mtRNA granules (MRGs) as sites for organization of mtRNA
processing, our improved understanding of the structure and composition of the mammalian
mitochondrial ribosome, and of the coordination required for concerted nuclear and mitochon-
drial gene expression.
The Mitochondrial Epitranscriptome: Chemical RNA Modiﬁcation for Gene
Regulation
Control of the transcriptome in any biological system requires numerous post-transcriptional
RNA modiﬁcations. In line with this, transcripts released from polycistronic mtRNA precursors
are subject to enzymatic nucleotide modiﬁcations in mammalian mitochondria (Box 1). Early
comprehensive biochemical work by Dubin et al. using hamster RNA identiﬁed a set of nine
well-conserved chemical modiﬁcations to the small (12S) and the large (16S) mt-rRNAs
(Figure 2) [104–107]. Most of these modiﬁcations have been conﬁrmed to be present in the
mt-rRNA of humans and other mammals, and several factors responsible for introducing these
modiﬁcations have been identiﬁed [11–14]. In 12S mt-rRNA, TFB1M is responsible for nucle-
obase dimethylation of adenines A936 and A937 [13,15], whereas NSUN4 methylates cytidine
at position 841 (human numbering) [14]. A group of closely related putative 20-O-ribose
methyltransferases (MRM1, MRM2/FtsJ2, and MRM3/RNMTL1) have been shown to be
involved in modiﬁcation of three nucleotide positions of the peptidyl transferase center of
16S mt-rRNA [11,12] (Figure 2). Very recently, a 10th modiﬁcation in mt-rRNA was identiﬁed
(16S: m1A947), initially by analyzing RNA–DNA differences (RDDs) in RNA-Seq experiments,
followed by biochemical conﬁrmation and identiﬁcation of TRMT61B as the enzyme responsi-
ble [16]. A systematic survey has revealed that 7% of all bovine mt-tRNA residues undergo
post-transcriptional modiﬁcation, with over 30 different modiﬁed mt-tRNA positions [17].
Several enzymes introducing these modiﬁcations have already been determined, but the list
is far from complete ([18,19] for recent comprehensive reviews). The number of modiﬁed
nucleotides in the mitochondrial non-coding RNA is generally greatly reduced compared to
their cytoplasmic or bacterial counterparts [20]. For example, the bacterial large 23S rRNA626 Trends in Biochemical Sciences, August 2017, Vol. 42, No. 8
Mitoribosome assembly
RNA endonucleolyc processing
RNA maturaon
(e.g., DDX28, FASTKD2,
MRM1–3, MRPs)
Translaon
(e.g., MRPP1–3, ELAC2)
mtDNA replicaon
mtDNA repair
mtDNA transcripon
(e.g., mtPAP, GRSF1,
RPUSD4, FASTK)
A A A 
A A A A A A A A A A A A A A A
RNA degradaon
(e.g., SUV3, PNPase)
Precursor
RNA
Inner mitochondrial membrane
Outer m
itochondrial m
em
brane
Interm
em
brane space
Mitochondrial
matrix
Crista lumen
A 
A A
 A A
 A A A A A A A A A A A A A
OxPhos assembly
m
tD
NA
Figure 1.
(Figure legend continued on the bottom of the next page.)
Mitochondrial Gene Maintenance and Expression: A Focus on Post-Transcriptional Processes. Proteins involved in mitochondrial gene
maintenance and expression have been localized to focal nucleoprotein structures in the mitochondrial matrix. These foci can be classiﬁed according to their protein
contents into nucleoids, which contain mitochondrial (mt)DNA and mtRNA granules (MRGs, represented in dark orange). Nucleoids and MRGs are present in close
spatial proximity in microscope analyses. Nucleoids contribute mainly to the maintenance of the genetic material of mitochondria and the synthesis of RNA.
Characterization of MRGs revealed the presence of a panoply of enzyme classes that perform diverse tasks necessary for the post-transcriptional expression of
mitochondrial genes, from RNA maturation to mitoribosome assembly. However, it is currently not clear if all post-transcriptional steps of mitochondrial gene expression
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Figure 2. Known Players in Mammalian Mitochondrial Ribosomal Biogenesis. Following endonucleolytic
cleavage of newly transcribed polycistronic mitochondrial RNA (mtRNA) transcripts, mitochondrial ribosomal RNAs
(mt-rRNAs) must undergo a series of nucleotide modiﬁcations. There are ﬁve known modiﬁed residues in mammalian
12S mt-rRNA and ﬁve in 16S mt-rRNA. The exact residues and their modiﬁcations are indicated in brackets and relate to
the position in human 12S or 16S mt-rRNA. Shown in blue are the enzyme factors that are known to modify the indicated
positions on mt-rRNAs. Several methyltransferases have been identiﬁed which modify mt-rRNAs, with NSUN4 and TFB1M
modifying 12S and TRMT61B, and MRM1, MRM2, and MRM3 modifying 16S, at the indicated positions. In addition,
pseudouridine synthase RPUSD4 has been identiﬁed as enzyme that is likely to provide the Psi1397 modiﬁcation. In
addition to nucleotide modiﬁers, several further protein factors are required for assembly of mitochondrial ribosomal
proteins (MRPs) into the mitochondrial large ribosomal subunit (mt-LSU), the mitochondrial ribosomal small subunit (mt-
SSU), or to aid in the formation of the complete monosome. These accessory factors are shown in orange. Although the
enzymatic role of some of these factors have been predicted or can be inferred from their bacterial homologs, such as the
putative RNA helicases MDDX28 and DHX30, or the proposed RNA chaperone ERAL1, the precise roles of many of the
indicated accessory factors in mitoribosome biogenesis have yet to be determined. ‘?’ indicates a known nucleotide
modiﬁcation or assembly step where the responsible factors are yet to be identiﬁed. Because MRPs have been found to
copurify with the mitochondrial nucleoid and mtRNA granules (MRGs), early steps of mitoribosome assembly are likely to
occur co-transcriptionally, in concert with mt-rRNA nucleotide modiﬁcations. The factors that have, thus far, been found to
localize to MRGs are in solid color. Abbreviations: LSU, large subunit; PSI, pseudouridine; SSU, small subunit.harbors 25 modiﬁcations (1%), whereas only ﬁve modiﬁed nucleotides have been detected in
human 16S mt-rRNA (0.3%). This suggests that the few mtRNA modiﬁcations that have been
retained are of high functional importance. One of the reasons for the lower level of mod-
iﬁcations on mtRNA could be the limitation of the number of nuclear DNA (nDNA)-encoded
protein factors that must be imported into mitochondria. Alternatively, it could have resulted
from an inability of mitochondria to adapt the small nucleolar (sno) RNA-guided modiﬁcation
mechanisms that operate in the cytoplasmic ribosome [21]. However, with only a few modiﬁed
nucleotides, mammalian mitochondria appear to have found alternative solutions for the properoccur in MRGs. RNA degradation, the last stage of RNA metabolism, has also been postulated to occur in specialized foci, termed D-foci (shown in light orange), that
contain the components of the mitochondrial degradosome, RNA helicase Suv3 and PNPase. A portion of D-foci have been found to colocalize with newly synthesized
mtRNA, in a similar manner to MRGs, and may represent a subpopulation of MRGs participating in RNA processing or degradation mediated by the degradosome.
Following maturation of all three classes of mtRNAs, mitoribosome assembly, and mt-tRNA aminoacylation, these molecules are now available for utilization in
mitochondrial protein synthesis. Mitoribosomes synthesize 13 OxPhos proteins encoded by mt-mRNAs, and these subunits are co-translationally inserted into the inner
mitochondrial membrane where they are incorporated into respiratory complexes together with nucleus-encoded OxPhos subunits. The stages of mitochondrial gene
expression relevant for this review are indicated in orange.
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Box 1. Key Steps in mtRNA Expression and Maturation
The human mitochondrial genome, or mtDNA, encodes 13 polypeptides, 22 mitochondrial transfer RNAs (mt-tRNAs),
and two ribosomal RNAs (mt-rRNAs). mtDNA transcription, therefore, provides all the RNA components required for
translation of its own messenger RNAs (mt-mRNAs). Genes are spread across both the heavy (H) and light (L) strands of
mtDNA. Instead of initiating at individual gene-speciﬁc promoters, transcription of mammalian mtDNA initiates from
single promoters for H- and L-strand transcription, and progresses around almost the entire length of the genome.
A single-subunit RNA polymerase, POLRMT, is responsible for mtDNA transcription, and provides both the promoter-
binding speciﬁcity and catalytic polymerase activity [86,87]. In addition, mitochondrial transcription factor A (TFAM),
mitochondrial transcription factor B2 (TFB2M), and mitochondrial transcription elongation factor (TEFM) are required for
efﬁcient transcription in vivo [88,89].
Because transcription results in polycistronic transcripts, the constituent mt-mRNAs, mt-tRNAs and mt-rRNAs must be
released via endonucleolytic cleavage. In the majority of cases, human mt-mRNAs and mt-rRNAs are ﬂanked at both the
50 and 30 ends by mt-tRNA genes, allowing their excision to release mt-mRNAs and mt-rRNAs via the ‘tRNA punctuation
model’ [90]. This cleavage is performed by a mitochondria-speciﬁc, protein-only RNase P complex [91] and ELAC2 [92],
which catalyze 50 and 30 endonucleolytic cleavage, respectively. There are, however, some exceptions where mt-tRNAs
are not positioned at mt-mRNA junctions. Although the exact mechanisms for cleavage at such non-canonical junctions
remain to be determined, recent studies have implicated FASTK, FASTKD4, and FASTKD5 as well as GRSF1 as factors
involved in these processes [49,64,65,70].
Following endonucleolytic processing, individual mt-mRNA, mt-rRNA, and mt-tRNA transcripts undergo post-tran-
scriptional modiﬁcations. Several nucleotides in mt-rRNAs are modiﬁed to facilitate mitoribosome biogenesis and
function before incorporation into the mitoribosome proteins (Figure 2). The only conﬁrmed modiﬁcation of mt-mRNAs is
the addition of a 30 poly(A) tail catalyzed by mitochondrial poly(A) polymerase (mtPAP) [93], with the exception of ND6
mt-mRNA which is not polyadenylated. Control of poly(A) tail length and RNA stability is achieved with the aid of the
complex of LRPPRC–SLIRP [94–96] and the PDE12 poly(A)-speciﬁc exoribonuclease [97].
Finally, mt-tRNAs undergo extensive post-transcriptional nucleotide modiﬁcation, in addition to 30 CCA trinucleotide
addition [18], before being aminoacylated with their cognate amino acid [98]. Following maturation of mt-RNAs and
mitoribosomes, they are available for use in mitochondrial protein synthesis.functioning of their tRNA and rRNA. This has been most strikingly demonstrated by the
complete mapping of post-transcriptional modiﬁcations in the mt-tRNAs of Bos taurus, in
which the very highly conserved m5U54 methylation is entirely absent [17]. The adaptive
changes that have arisen to compensate for its loss, however, are currently unclear.
RNA Epigenetics: NSUN3 and ABH1 As New Players in Decoding Mitochondria-Speciﬁc
Codons
One of the recently investigated unique features of mitochondrial gene expression concerns the
post-transcriptional modiﬁcation of mt-tRNAMet and decoding of methionine codons. In the
cytosol of eukaryotic cells there are two distinct types of tRNAMet that are used for either
translation initiation or elongation. However, as a consequence of the reductive evolution of
mtDNA, metazoan mitochondrial transcriptomes contain a minimal set of tRNAs, where each
mt-tRNA species usually decodes an increased number of codons. In line with this, human
mtDNA contains only one gene encoding mitochondrial tRNAMet that is used for both initiation
and elongation stages of mitochondrial protein synthesis. However, in addition to decoding the
universal AUG codons, this single mt-tRNAMet also recognizes the unconventional AUA (which
codes for isoleucine in the universal genetic code) during initiation and elongation [22,23]. In the
human mitochondrial genome, 167 methionine residues are encoded by AUA, and only 40 use
the standard AUG codon. Furthermore, mt-tRNAMet can also decode AUU and AUC, but only
as initiation codons (during elongation AUU and AUC are decoded as isoleucine, as in the
standard genetic code). It has previously been shown in vitro that a 5-formyl modiﬁcation of the
cytosine residue in the wobble position of the anticodon (f5C34) in human mt-tRNAMet allows
decoding of AUG and the non-conventional AUN codons [23,24]. Even though mt-tRNAMet
f5C34 was ﬁrst detected over 20 years ago [22], until recently the source of the formyl group and
the enzyme(s) involved in generating this modiﬁcation remained unknown.Trends in Biochemical Sciences, August 2017, Vol. 42, No. 8 629
Three independent studies have recently enabled identiﬁcation of the sequential mechanism
responsible for the f5C34 modiﬁcation of the wobble cytosine in mt-tRNAMet [25–27]. Using a
variety of different approaches, the three laboratories found that this nucleobase is initially
modiﬁed with a methyl group (m5C) that is subsequently oxidized to a formyl group, generating
f5C. The enzyme responsible for the methylation step has been identiﬁed as NSUN3, a
mitochondria-targeted member of the Nol1/Nop2/Sun domain (NSUN) family of m5C RNA
methyltransferases. Inactivation of NSUN3 resulted not only in reduced levels of m5C34 but
also in decreased levels of f5C34. This observation proved that methylation constitutes an
intermediate step in the pathway of formylation of the mt-tRNAMet wobble cytosine. One of
these three studies [25] has also identiﬁed the enzyme responsible for methyl- to formylcy-
tosine conversion as ABH1 (also known as ALKBH1). ABH1 belongs to a family of Fe2+/
a-ketoglutarate-dependent dioxygenases. Inactivation of either NSUN3 or ABH1 led to
defects in mitochondrial translation. However, it is currently not clear whether the entire
functional pool of mt-tRNAMet is formylated at C34 in vivo, with the methylated form being
merely an intermediate, or whether differentially modiﬁed mt-tRNAMet pools are present in
mitochondria. Because a-ketoglutarate is an important intermediate of the Krebs cycle, the
levels of a-ketoglutarate could potentially inﬂuence methyl to formylcytosine conversion by
ABH1 and, as such, regulate the m5C34/f5C34 ratio. It will be fascinating, therefore, to
establish if alterations to the relative abundance of different RNA modiﬁcations could poten-
tially participate in the regulation of mitochondrial translation as a response to changes in the
metabolic state of the cell.
RNA Pseudouridylation: A New Twist
Pseudouridine (C), the most common modiﬁcation in non-coding RNA, is a structural isomer of
uridine and the only mass-silent RNA modiﬁcation identiﬁed so far [28]. As do their cytoplasmic
counterparts, mt-tRNAs contain pseudouridylated residues [17]. It has also been determined
that mammalian 16S mt-rRNA contains at least one C [29] (Figure 2). The roles of individual Cs,
the enzymes responsible for these modiﬁcations, and how they inﬂuence the structure and
function of different mtRNA classes remain to be clariﬁed. Of several conserved human C
synthases, only PUS1 has previously been characterized as an mt-tRNA modifying enzyme
(positions 27 and 28) and has been linked to human disease [30]. However, a recent genome-
wide CRISPR ‘death screen’ identiﬁed three previously uncharacterized, putative C synthases
(RPUSD3, RPUSD4, and TRUB2) as being essential for OxPhos [31]. Depletion of any of these
genes results in decreased levels of 16S mt-rRNA and perturbs mitochondrial translation. Very
recently, these three putative mitochondrial C synthases were shown to localize to MRGs, the
concept of which is discussed in greater detail below [32,33]. Furthermore, RPUSD4 is
probably the enzyme responsible for pseudouridylation of position 1397 of 16S mt-rRNA
[32]. This is consistent with a further study which demonstrated instability of 16S mt-rRNA upon
RPUSD4 silencing [33]. However, further research will be necessary to determine the exact role
of 16S mt-rRNA pseudouridylation, especially in the context of mitochondrial ribosome bio-
genesis (Figure 2 and see below).
A further high-throughput study that analyzed transcriptome-wide occurrence of Cs indicated
that, in addition to non-coding RNA, mt-mRNAs also contain this modiﬁcation [34]. Although a
more targeted validation of this ﬁnding is required, mt-mRNA pseudouridylation could emerge
as an important regulatory mechanism; for example, by rewiring the genetic code via non-
canonical base pairing in the ribosome decoding center. Characterizing the landscape, enzy-
mology, and potential dynamic changes in pseudouridylation of the mitochondrial transcrip-
tome is likely to be a subject of intense study in the near future.
As we describe above, the ﬁeld has experienced rapid expansion in our knowledge of the
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(e.g., NSUN3, ALKBH1, C synthases). However, further work will be necessary to fully
characterize the mitochondrial epitranscriptome and the functional role for each RNA modiﬁ-
cation in the context of mt-tRNA biology and mitoribosome biogenesis.
Mitoribosome Structure and Biogenesis
Recent developments in cryo-electron microscopy (cryo-EM) have transformed our access to
3D structures of protein complexes that have thus far been refractory to other methods. The
near-atomic resolution structure of mammalian mitochondrial ribosomes (mitoribosomes) has
recently been obtained, revealing several unexpected features [35–38] (Box 2).
Plasticity of Structural RNA Selection by the Mammalian Mitoribosome
Mammalian mitoribosomes differ from other ribosomes by the unexpected integration of a
mitochondria-encoded tRNA as a structural element of the central protuberance (CP) region of
the large subunit (mt-LSU). Interestingly, different mt-tRNAs have been reported to be present
in human (mt-tRNAVal) and porcine (mt-tRNAPhe) mitoribosomes [35,36]. In other ribosomes,
the CP region is conventionally occupied by 5S rRNA. In addition, the mammalian mitoribo-
some was initially thought to contain cytosolic 5S RNA based on co-immunoprecipitation of this
RNA molecule with mt-LSU [39]. Therefore, the recent cryo-EM structural studies haveBox 2. The Mammalian Mitochondrial Ribosome
The mammalian mitochondrial ribosome (mitoribosome) is specialized for the translation of the 13 mitochondria-
encoded components of the OxPhos system. The two subunits of the mitoribosome, the 28S small subunit (mt-SSU)
and the 39S large subunit (mt-LSU), comprise a catalytic RNA – 12S mt-rRNA and 16S mt-rRNA, respectively –
encased in protein subunits (MRPs).
The co-evolution of the mammalian mitoribosome along with the highly hydrophobic OxPhos subunits has resulted in
drastic changes to the composition and architecture of the mitoribosome complex. Compared to bacterial, eukaryotic
cytoplasmic ribosomes, and yeast mitoribosomes, the RNA component of the mammalian mitoribosome is about half
the length, and this may be a consequence of reductive evolution of the mitochondrial genome [99]. To compensate for
the severe reduction in rRNA size, the mitoribosome has recruited more protein subunits to stabilize the structure and
compensate for loss of functional domains [37,38]. In contrast to the 55 ribosomal proteins in the bacterial ribosome,
and the 70 proteins in the yeast mitoribosome, the mammalian mitoribosome consists of 80 protein subunits. In
addition, many RNA–RNA interactions which bridge between the large and small subunits in the bacterial and eukaryotic
cytoplasmic ribosomes have been replaced by protein–protein and protein–RNA bridges in the mammalian mitoribo-
some [37,38].
The remodeling of the mitoribosome is particularly noticeable in the central protuberance (CP) region, which in bacterial,
archaeal, and eukaryotic cytoplasmic ribosomes contains a 5S rRNA component. In the mammalian mitoribosome this
has been replaced by an mtDNA-encoded tRNA. The identity of the tRNA assembled into the mitoribosomes varies
depending on the organism. Both mt-tRNAVal and mt-tRNAPhe have been shown to be present in the CP [35,36,100].
Both these mt-tRNAs are located adjacent to mt-rRNAs in the human mitochondrial genome, allowing co-transcrip-
tional maturation and assembly into the mitoribosome. Moreover, mammalian mitoribosomes have acquired a GTP-
hydrolyzing protein (mS29) and a pentatricopeptide repeat (PPR) protein (mS39), the functions of which are not fully
understood [9].
The polypeptide exit tunnel of the mitoribosome has also become specialized for the translation of hydrophobic
membrane proteins. The exit tunnel of the mitoribosome is positioned such that nascent polypeptide can be
cotranslationally inserted into the membrane and the large subunit of the translating monosome is attached to the
membrane by the C-terminal helix of mL45. Moreover, residues lining the tunnel surface are hydrophobic to regulate the
rate at which of the newly synthesized polypeptide exits from the mitoribosome [35,36].
Although the recently resolved cryo-EM structures have rapidly accelerated our understanding of the structural
composition of the mitoribosome, they do have some limitations, warranting further study. During translation, mam-
malian mitoribosomes must be localized to the inner mitochondrial membrane, in association with the protein machinery
required for membrane insertion of elongating polypeptides, which remains to be fully characterized. Therefore, further
structural studies to address the exact nature of the interaction of actively translating mitoribosomes with the inner
mitochondrial membrane would be highly advantageous.
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resolved the longstanding conundrum of whether or not mammalian mitoribosomes contain a
5S rRNA. These studies have recently been extended to show that mammalian species in
general can incorporate different mt-tRNAs into the mt-LSU [40]. However, of 22 mitochondria-
encoded tRNAs, only mt-tRNAVal and mt-tRNAPhe were found to be incorporated into the mt-
LSU, and there was no evidence for tissue-speciﬁcity. Most astonishingly, however, we
revealed the plasticity of this arrangement by analyzing a patient-derived cell line harboring
a mutation in mt-tRNAVal, which results in a greatly reduced global steady-state level of mt-
tRNAVal. Under these conditions of limiting availability of mt-tRNAVal, the human mitoribosome
was able to switch from incorporating mt-tRNAVal to mt-tRNAPhe. Moreover, human mitor-
ibosomes containing mt-tRNAPhe were shown to be translationally competent [40].
The substitution of 5S by a mitochondria-encoded tRNA in the mitoribosome could stem from
the inability of the mammalian organelle to efﬁciently import RNA from the cytoplasm (discussed
in [41]). The selection of mt-tRNAVal and mt-tRNAPhe as structural components of the mt-LSU is
most likely related to the position of these genes in the mammalian mitochondrial genome. In
prokaryotes, the 5S rRNA is part of a polycistronic transcript that also contains the small and
large rRNAs. An analogous gene arrangement is found in most mammalian mitochondrial
genomes, with mt-tRNAVal and mt-tRNAPhe ﬂanking the two mt-rRNA genes. This gene
arrangement in mammalian mtDNA confers a spatial advantage and stoichiometric availability
of the mt-tRNA and mt-rRNA species for incorporation into the mt-LSU. However, the reason
why different mt-tRNAs are found in mitoribosomes of closely related mammalian species
remains to be addressed. In addition, it would be interesting to investigate the incorporation of
structural RNAs into mitoribosomes in species where the arrangement of mt-rRNA and mt-
tRNA on mtDNA is different from that of mammals.
Building Mitoribosomes: New Players in the Assembly Pathway
In all systems studied thus far, ribosome biogenesis entails a complex, multistep, and tightly
regulated pathway. In budding yeast, approximately 200 proteins and 70 snoRNAs have been
reported to participate in the production of the cytoplasmic ribosome. Many of these proteins
directly facilitate the assembly or transport of pre-ribosomal complexes from the nucleolus to
the cytoplasm [42]. In bacteria, the absence of cellular compartmentalization reduces the
number of proteins required for ribosome synthesis. Nonetheless, approximately 80 assembly
factors, rRNA modiﬁers, and rRNA processing enzymes are involved in the biosynthesis of the
bacterial ribosome [43]. In contrast to the relatively well-characterized ribosomal assembly
pathways in bacteria and in eukaryotic cytoplasm, studies addressing the biogenesis of the
mammalian mitoribosome have only recently commenced and are in their infancy [44]. We
summarize below the recently discovered factors associated with the mitoribosome biogenesis
process and discuss how further studies of these factors could be useful in elucidating
mitoribosome assembly.
Several protein factors have thus far been identiﬁed to play roles in the assembly of the small
subunit of the mitoribosome (mt-SSU) (Figure 2). Two previously mentioned 12S mt-rRNA
methyltransferases, NSUN4 and TFB1M, have been implicated in mt-SSU biogenesis. NSUN4
has been shown to have a dual function: although it is required for 12S methylation, NSUN4
additionally functions in complex with MTERF4 to play a role in regulating monosome assembly,
presumably by binding to the mt-LSU and facilitating interaction with the mt-SSU [14,45].
Ablation of TFB1M causes a reduction in 12S mt-rRNA steady-state level, leading to a
deﬁciency of assembled mt-SSU [13]. ERAL1, a homolog of the bacterial Era protein, is a
member of the conserved family of GTP-binding proteins and has been suggested to function
as an RNA chaperone that protects 12S mt-rRNA on the mt-SSU during assembly [46,47]. In
addition, the C4orf14 (NOA1) GTPase interacts with the mt-SSU, and its knockdown leads to a
defect in small subunit assembly [48].632 Trends in Biochemical Sciences, August 2017, Vol. 42, No. 8
Our knowledge about the factors required for the assembly of the mt-LSU has also rapidly
expanded (Figure 2). In addition to the mt-SSU, methyltransferases have also been implicated
in the biogenesis of the mt-LSU. Downregulation of MRM2 or MRM3 results either in diminished
levels or altered sucrose-gradient sedimentation of the mt-LSU, respectively [12]. However, it is
currently not clear whether the absence of methyltransferase activity or simply the lack of the
protein results in the aberrant production of mt-LSU. Two RNA-binding proteins, MTERF3 and
FASTKD2, and a putative RNA helicase, DDX28, have been implicated in the assembly of the
mt-LSU, although the molecular mechanisms are not understood [49–52]. A more pleiotropic
effect on the mitoribosome was observed when the expression of RNA-binding protein GRSF1
or the putative helicase DHX30 was suppressed – this resulted in the accumulation of mt-SSU
subassemblies and a decrease in mt-LSU and monosome content [49]. Similarly, a MPV17
protein family member, MPV17L2, was found to associate with the mt-LSU, but its knockdown
led to instability of both the mt-LSU and mt-SSU [53]. Finally, MALSU1, a member of the
ribosome silencing factor (RsfS) family [54], has been involved in assembly and/or stability of the
mt-LSU [55–57]. It remains to be determined whether MALSU1, similarly to its bacterial
homolog, exhibits ribosome silencing activity, preventing premature association of the small
and large subunits to form the monosome.
Current knowledge of the functional role of the identiﬁed mitoribosome biogenesis factors does
not allow their conﬁdent assignment to particular steps in the assembly process. Without further
studies, it is difﬁcult to draw any meaningful parallels in the assembly process between the
mitoribosome and its cytoplasmic or bacterial counterparts. However, a growing inventory of
mitochondrial factors involved in mitoribosome production is expected to contribute to future
investigations on the molecular details of its sequential assembly. Recent application of afﬁnity
puriﬁcation of pre-ribosomal particles using an epitope-tagged assembly factor, combined with
subsequent cryo-EM analysis, has enabled snapshots of compositionally and structurally different
intermediates of budding yeast cytoplasmic ribosome biogenesis to be acquired, providing
essential mechanistic details [58]. An analogous approach could be adapted for selected mito-
chondrial factor(s) that have already been shown to participate in mitoribosome production.
Further, inactivation of speciﬁc mitoribosomal biogenesis factors can result in the accumulation of
on-pathway intermediates which, again, could be analyzed by cryo-EM or proteomic proﬁling [59].
These approaches are likely to uncover novel assembly factors that remain attached to these
incompletely assembled mitoribosomes, and could be helpful in building detailed assembly maps.
Regulation and Coordination of Mitochondrial Gene Expression
The processes by which the basic stages of gene expression are regulated in mammalian
mitochondria to adapt to metabolic demand are still not well understood. Several recent studies
have brought to light the previously unknown organization of newly synthesized mtRNAs into
dynamic nucleoprotein structures, the MRGs (Box 3). These subcompartments may provide
spatiotemporal regulatory function for mtRNA post-transcriptional processing, allowing mt-
mRNAs, mt-tRNAs and mt-rRNAs to be matured fully before release for use in protein synthesis.
In addition, owing to the dual genetic origin of subunits of OxPhos complexes, there is a
necessity for coordination of gene expression of both genomes. While this may be achieved
through control of transcription and mtRNA maturation of both genomes, direct regulation of
mitochondrial protein synthesis is emerging as another likely stage for ensuring correct
production and assembly of OxPhos subunits. We discuss below recent breakthroughs in
our understanding of how mitochondrial gene expression is coordinated.
mtRNA Granules: A Subcompartment for RNA Maturation and Ribosome Assembly
Since ﬁrst being imaged via microscopy using ﬂuorescent (DAPI, 40,6-diamidino-2-
phenylindole) staining of DNA, mtDNA has been observed to be located in discrete punctaeTrends in Biochemical Sciences, August 2017, Vol. 42, No. 8 633
Box 3. Mitochondrial RNA Granules (MRGs)
From their synthesis to degradation, mtRNAs undergo several transformation steps in which diverse molecular players
are involved, all with the aim of enabling the faithful production of mtDNA-encoded proteins.
Maturation of mtRNAs comprises processes such as synthesis, cleavage of 50 and 30 ends, modiﬁcation of key
nucleotides, editing of 30 ends, decoding, and eventual degradation (Box 1). The enzymes which perform these tasks
are not randomly distributed in the mitochondrial matrix but are enriched in punctate structures, or foci, providing
dedicated centers that participate in different stages of mtRNA metabolism.
Studies on the localization of speciﬁc mitochondrial proteins, bromouridine (BrU) incorporation, and mtDNA immu-
nostaining have enabled the identiﬁcation and characterization of foci containing nascent transcripts, called MRGs.
Although found in the vicinity of mtDNA-containing foci, they are structurally distinct from nucleoids [64,68]. Diverse
classes of proteins are present in MRGs. The presence of enzymes involved in the processing of mtRNAs (GRSF1
[64,68], RNase P subunits [64], and mtPAP [69]) and the post-transcriptional nucleotide modiﬁcation of non-coding
mtRNAs (e.g., MRM2, MRM3 [67], TFB1M, PUS1 [49], and TRMT10C [100]) led to the conceptualization of MRGs as
RNA maturation centers in mitochondria.
Furthermore, because mitoribosome assembly factors (e.g., MTERF3/MTERFD1, ERAL1, DDX28, and FASTK-family
proteins [49,52]) (Figure 2) and integral mitoribosome components (i.e., mt-rRNAs and mitochondrial ribosome proteins
[64]) are gathered in MRGs, they have been postulated to be involved in regulating mitochondrial translation.
The last stage in the life of mtRNAs has also been proposed to take place in dedicated foci, termed D-foci [66] for its
principal component, the degradosome complex. The degradosome complex is formed by mitochondrial helicase Suv3
[101] and polynucleotide phosphorylase (PNPase) [102,103].
Although a proportion of identiﬁed D-foci also colocalize with newly synthesized RNA, similarly to MRGs, further
investigation will be necessary to verify whether these foci form a subset of MRGs or are separate entities with a distinct
composition and purpose.throughout the mitochondrial network [60]. Immunostaining experiments indicated that a range
of proteins, with roles associated with mtDNA maintenance (such as packaging and replication)
and transcription of the mitochondrial genome, colocalize with these mtDNA foci [61]. Together
with mtDNA, these associated proteins form a nucleoprotein complex known as the mito-
chondrial nucleoid (Figure 1). A recent study which sought to clarify their functional organization
has suggested that nucleoids are almost exclusively comprised of a single copy of mtDNA, and
the compacted nucleoid structure is achieved through an interaction with mitochondrial
transcription factor A (TFAM) [62].
Newly transcribed mtRNAs were found in discrete foci situated in close proximity to
mitochondrial nucleoids [63]. These foci, known as MRGs (Box 3), have been found to
contain numerous proteins involved in post-transcriptional processing and regulation of
mtRNA, as well as factors involved in mitoribosome assembly (Figure 2) [49,64–69]. By
tracking the progress of nascent RNA transcripts through the incorporation of the uridine
analog 5-bromouridine (BrU), together with the colocalization of protein factors for RNA
processing [64,68] (Boxes 1,3), these foci have come to be recognized as compartmental-
ized centers for RNA processing. Newly identiﬁed RNA-binding proteins were found to
localize to MRGs, whose function is crucial for the activities housed within them. G-rich RNA
sequence binding factor 1 (GRSF1), for example, interacts with the RNase P complex, and its
loss leads to aberrant mtRNA processing [64] and a mitochondrial translation defect [64,68].
More recently, systematic approaches towards the characterization of the MRG proteome
has led to the identiﬁcation of further proteins involved in post-transcriptional mtRNA
metabolism, including Fas-activated serine/threonine kinase (FASTK) protein family mem-
bers FASTK and FASTKD5 [49,65]. A further FASTK family member, FASTKD4, has also
been implicated in mt-RNA processing, although this polypeptide has not yet been found to
localize to MRGs [70].634 Trends in Biochemical Sciences, August 2017, Vol. 42, No. 8
In addition to MRGs, both components of the mitochondrial degradosome, RNA helicase Suv3
and 30!50 exoribonuclease polynucleotide phosphorylase (PNPase), have been found to
localize in discrete punctae known as D-foci [66]. A portion of these identiﬁed D-foci colocalize
with newly synthesized, BrU-labeled mtRNAs, and therefore potentially overlap spatially and
functionally with MRGs (Figure 1). These D-foci, therefore, may contain speciﬁc mtRNAs that
require the action of the degradosome for their maturation, for example ND6 [65], or may
represent turnover events of newly synthesized but misprocessed RNAs.
Many factors necessary for mitoribosome biogenesis have also been localized in MRGs
(Figure 2). Hence, it has been proposed that MRGs are also centers for mitoribosome
biogenesis, with a function analogous to that of the nucleolus where initial steps of cytoplasmic
ribosome assembly are performed [49,52,71]. Fractionation-based enrichment experiments
suggested that nucleoids copurify with mitochondrial factors involved in mtRNA metabolism,
mitoribosome biogenesis, and translation, as well as with mitochondrial ribosomal proteins
(MRPs). The latter have also been found to reside in MRGs [48,72,73]. It has been suggested
that early steps of mitoribosome assembly take place co-transcriptionally, with incorporation
and assembly of MRPs occurring in concert with mt-rRNA nucleotide modiﬁcations [74,75].
This overlap in the protein complement associated with either the mitochondrial nucleoid or
MRGs suggests intimate association of these two entities. Therefore, it is possible that both
mtDNA and its transcription products are partitioned within non-membrane compartments to
provide a greater degree of spatiotemporal regulation of mtRNA processing, for example, by
sequestering immature mtRNAs within MRGs, away from mitochondrial translation processes
[76] (Figure 1).
Coordination of nDNA and mtDNA Gene Expression
Owing to the dual genetic origin of OxPhos complexes, there is a need for tight coordination
between the synthesis of nucleus-encoded and mtDNA-derived components to prevent the
accumulation of unafﬁliated subunits in the mitochondrial membrane. In the past this problem
was investigated mainly in the context of transcriptional response by the nucleus-encoded
mitochondrial genes (e.g., [77]). However, whether the translation of nucleus-encoded and
mitochondria-encoded transcripts change concordantly was not clear. A recent study in yeast
has sought to address the mechanisms responsible for controlling the mitochondrial–nuclear
protein balance using whole-cell genomic proﬁling approaches upon switching from anaerobic
to oxygen-dependent respiration [78]. In response to nutrient shift, the nucleus-encoded
OxPhos mRNAs are induced rapidly, with mitochondria-encoded OxPhos messages being
upregulated much more slowly. However, yeast ribosome proﬁling experiments revealed that,
during adaptation from anaerobic to aerobic growth, mitochondrial and cytosolic translation are
regulated in a rapid and coordinated manner. Furthermore, this adaptation is unidirectional
because mitochondrial gene expression was dependent on cytosolic translation and the import
of nucleus-encoded factors into mitochondria, whereas inhibition of mitochondrial protein
synthesis had no effect on the translation efﬁciency of nucleus-encoded OxPhos subunits.
In yeast, many transcript-speciﬁc activators, that have roles in initiation and\or elongation,
control the translation of mitochondrial mRNAs [79]. Unraveling the roles of these translation
activators in mediating the synchronized cytoplasmic–mitochondrial response will be an
important goal for future research.
There are signiﬁcant differences, however, between the genetic systems of yeast and mam-
malian mitochondria, and it will be necessary to determine whether the transcription/translation
control observed in yeast during adaptation of OxPhos to different metabolic settings is a
universal process. For instance, the structures of mammalian mt-mRNAs differ signiﬁcantly
from those of their yeast counterparts (the lack of introns, very short or absent untranslated
regions, or the presence of polyadenylation in mammalian mRNAs). In addition, only oneTrends in Biochemical Sciences, August 2017, Vol. 42, No. 8 635
Outstanding Questions
What further factors are involved in post-
transcriptional mtRNA modiﬁcations?
How is processing at non-canonical
cleavage sites in polycistronic mtRNA
transcripts achieved?
What are the precise roles of mtRNA
nucleotide modiﬁcations in mitochon-
drial ribosome biogenesis and/or
translation regulation?
How is assembly of mitochondrial ribo-
somal proteins into the large and small
mitoribosomal subunits regulated?
What functional roles do MRGs play in
the spatial and temporal organization
of mtRNA processing?
What signals/mechanisms are required
for concerted translation of cytoplasmic
and mitochondrial OxPhos mRNAs?mitochondrial translation activator has been identiﬁed in mammalian mitochondria [80,81],
suggesting the mechanisms of mammalian mitochondrial gene regulation have diverged
signiﬁcantly from those found in yeast. For these reasons, the application of similar whole-
cell genome approaches to mammalian systems would be advantageous.
Feedback mechanisms that ﬁne-tune the translation of a subset of mitochondria-encoded
proteins to optimize the levels of assembled into OxPhos complexes have been a subject of
intense research in yeast [82,83]. By contrast, much less is known about these processes
during the biogenesis of the mammalian OxPhos system. A very recent study has identiﬁed
‘mitochondrial translational plasticity’ as a means to coordinate the assembly of cytochrome c
oxidase (COX, complex IV) with mitochondrial translation stalling and restarting according to
the availability of nucleus-encoded subunits [84]. The authors found that, in the absence of
COX4 (the ﬁrst incorporated nucleus-encoded COX subunit), translation of mtDNA-encoded
COX1 is halted, resulting in stalled ribosomes carrying nascent COX1 peptides associated with
the early COX assembly intermediates [84]. This represents a novel pathway of mitochondrial
translational control whereby lack of an available nucleus-encoded OxPhos subunit binding
partner acts as a direct signal to inhibit mitochondrial translation, preventing the accumulation
of an excess of mtDNA-derived subunits that are unafﬁliated to OxPhos complexes.
It will be intriguing to determine, through applying a similar experimental approach, whether
there is related translational plasticity during the assembly of the other OxPhos complexes with
dual genetic origin (complexes I, III, and ATP synthase).
Concluding Remarks and Future Perspectives
Recent years have brought many important insights into the regulation of mtDNA gene
expression. Several novel factors have been identiﬁed, either via basic research approaches,
or through the study of patients with respiratory chain disorders. The characterization of these
factors has furthered the basic understanding of their function in the context of mtRNA
metabolism and translation, in addition to shedding new light upon these processes. None-
theless, many fundamental questions, frequently related to the pathology of mitochondrial
diseases, remain unanswered and new questions have arisen (see Outstanding Questions).
The future research of mitochondrial gene expression is expected to continue focusing on the
regulatory function of post-transcriptional mtRNA modiﬁcations as well as on the biogenesis of
the mitoribosome and of RNA granules. The application of genome-wide approaches to study
mtDNA gene expression, such as ribosome proﬁling, is expected to be more widespread as a
tool to investigate the basic features and pathology-related defects of mitochondrial protein
synthesis. Studies of the molecular mechanisms that govern mtDNA gene expression are
impeded by the inability to manipulate the mitochondrial genome at will, hence a routine
analysis of the role of cis-acting elements involved in mitochondrial transcription or RNA
maturation is currently impossible [85]. Therefore, future work should also focus on resolving
this practical issue to enable a reverse genetics approach for a comprehensive structure–
function study of mtDNA gene expression. Finally, the development of an in vitro system for
mitochondrial translation would be useful to directly establish the mechanistic details of intra-
mitochondrial protein synthesis. This task is currently confounded, however, by our incomplete
understanding of the basic components required and the need for membrane association of
the mitochondrial translation machinery.
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